InvestorsHub Logo
Followers 6
Posts 1095
Boards Moderated 0
Alias Born 07/18/2006

Re: None

Friday, 01/15/2021 10:09:45 AM

Friday, January 15, 2021 10:09:45 AM

Post# of 17590
Does anyone here have a subscription to STAT?

There's an article today by Adam Feuerstein re Aurina- it's said to be quite positive. Here's the teaser to it:

Aurinia’s kidney drug on the cusp of FDA approval
Next week, the Food and Drug Administration is expected to approve a new medicine from Aurinia Pharmaceuticals that will be used to treat patients with lupus nephritis, a serious autoimmune kidney disease.

If the FDA clearance goes through, the oral drug called voclosporin will be the first commercial product developed successfully by Aurinia, a drugmaker founded in 1993 and based near Vancouver, Canada. Voclosorin has the potential to deliver $1 billion or more in annual sales, but Aurinia has never launched a drug before, and it must do so during a Covid pandemic and with Big Pharma competition.

“We’re in a show-me phase right now, we know that, but we look forward to doing it,” said Aurinia CEO Peter Greenleaf, in an interview with STAT’s Adam Feuerstein.


I do not subscribe but wonder what the rest of the article stated.

TIA if anyone can provide details.

GLTA

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News